Louisa P. Rodriguez - 17 May 2023 Form 4 Insider Report for Orion Biotech Opportunities Corp.

Reporting relationship: Director
Issuer ticker: N/A
Reported as of: 17 May 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 18 May 2023, 16:05:06 UTC
Prior SEC filing: 25 Apr 2023
Next SEC filing: 07 Jun 2024
Source filing: View source filing
Reporting owner signature: /s/ Marcello Liguori, as attorney in fact for Louisa Rodriguez

Key filing fact

Louisa P. Rodriguez filed Form 4 for Orion Biotech Opportunities Corp. on 18 May 2023.

Key facts

This page summarizes Louisa P. Rodriguez's Form 4 filing for Orion Biotech Opportunities Corp..
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 18 May 2023, 16:05.

Change

Previous filing in this sequence was filed on 25 Apr 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ORIA transaction Derivative

Class B ordinary shares

Disposed to Issuer

Transaction value: $0
Shares: -40,000
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 17 May 2023
Ownership: Direct
Underlying class: Class A ordinary shares
Underlying amount: 40,000
Exercise price
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Louisa P. Rodriguez is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 1 footnote

Footnote F1

On April 21, 2023, the Issuer announced that it will not consummate an initial business combination within the time period required. Pursuant to the Issuer's Amended and Restated Memorandum and Articles of Association (the "Articles") and in connection with the winding up of the Issuer, the Class B ordinary shares, par value $0.0001, held by the Reporting Person were surrendered for no compensation on May 17, 2023.

SEC remarks

After giving effect to the Issuer's delisting and deregistration, the Reporting Person will no longer be subject to Section 16 reporting obligations.